Individuals with Down syndrome are at a much greater risk of developing Alzheimer’s disease, with inflammation of the brain starting early in life and the risk of Alzheimer’s reaching nearly 80% by the age of 60.
The root cause of Alzheimer’s disease is unknown. However, its frequency in patients with Down syndrome suggests that targeting inflammation in preclinical models of that syndrome could be an attractive strategy for designing therapies to promote healthier…